polymyxin B
Selected indexed studies
- Clinical Use of Polymyxin B. (Adv Exp Med Biol, 2019) [PMID:31364080]
- Polymyxin B versus colistin: an update. (Expert Rev Anti Infect Ther, 2015) [PMID:26488563]
- Polymyxin B and silver nanoparticles: a nanotechnology-driven approach to overcome antibiotic resistance. (Drug Dev Ind Pharm, 2025) [PMID:40757877]
_Worker-drafted node — pending editorial review._
Connections
polymyxin B is a side effect of
Sources
- Clinical Use of Polymyxin B. (2019) pubmed
- Polymyxin B versus colistin: an update. (2015) pubmed
- Polymyxin B and silver nanoparticles: a nanotechnology-driven approach to overcome antibiotic resistance. (2025) pubmed
- Polymyxin B accelerates the α-synuclein aggregation. (2021) pubmed
- Polymyxin B hemoperfusion: a mechanistic perspective. (2014) pubmed
- Polymyxin B delivery systems: smart solutions for improved antibacterial activity and reduced toxicity. (2025) pubmed
- Polymyxin B, colistin, and sodium colistimethate. (1982) pubmed
- Colistin and polymyxin B: peas in a pod, or chalk and cheese? (2014) pubmed
- Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. (2007) pubmed
- Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters. (2024) pubmed